Neurologic Complications of Cancer Chemotherapy Review uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Nervous System Diseases

abstract

  • Neurotoxicity related to cancer therapy is a common problem in oncology practice. Neurologic side effects can be dose-limiting, can inhibit treatment, and can substantially diminish quality of life. Symptoms may appear acutely after treatment, or remotely after therapy has been discontinued. Multiple therapies may share similar toxicities, and certain agents may potentiate symptoms. When faced with the development of neurologic complaints, familiarity with the most common complications is helpful in determining the etiology of these symptoms. This review will discuss the common complications of both established and novel agents used to treat cancer.

publication date

  • June 2006

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1053/j.seminoncol.2006.03.006

PubMed ID

  • 16769421

Additional Document Info

start page

  • 324

end page

  • 32

volume

  • 33

number

  • 3